Compare RPC & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RPC | SDGR |
|---|---|---|
| Founded | 1992 | 1990 |
| Country | United States | United States |
| Employees | 267 | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 932.7M | 850.5M |
| IPO Year | N/A | 2020 |
| Metric | RPC | SDGR |
|---|---|---|
| Price | $7.97 | $12.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $11.00 | ★ $21.00 |
| AVG Volume (30 Days) | 839.6K | ★ 1.2M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.91% | N/A |
| EPS Growth | N/A | ★ 45.14 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $255,869,000.00 |
| Revenue This Year | $16.82 | $0.76 |
| Revenue Next Year | $15.80 | $4.60 |
| P/E Ratio | $53.06 | ★ N/A |
| Revenue Growth | N/A | ★ 23.29 |
| 52 Week Low | $6.79 | $10.95 |
| 52 Week High | $9.32 | $27.63 |
| Indicator | RPC | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 60.10 | 61.42 |
| Support Level | $6.94 | $11.03 |
| Resistance Level | N/A | $13.36 |
| Average True Range (ATR) | 0.30 | 0.58 |
| MACD | 0.13 | 0.19 |
| Stochastic Oscillator | 86.82 | 95.63 |
Ridgepost Capital Inc, formelrly P10 Inc is a player in the alternative asset management sector, specializing in multi-asset class private market solutions. It offers a range of investment solutions, including specialized funds, separate accounts, secondary investments, direct investments, and co-investments across various asset classes and geographies. These solutions cater to diverse investor needs within the private markets, aiming to deliver superior risk-adjusted returns. With a focus on middle and lower-middle markets, the company's portfolio includes Private Equity, Venture Capital, Impact Investing, and Private Credit. Its Revenue primarily comes from recurring management and advisory fees earned on committed capital, typically locked up for ten to fifteen years.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.